1. Home
  2. NEXT vs HROW Comparison

NEXT vs HROW Comparison

Compare NEXT & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextDecade Corporation

NEXT

NextDecade Corporation

HOLD

Current Price

$5.60

Market Cap

1.5B

Sector

Energy

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$36.36

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXT
HROW
Founded
2010
1998
Country
United States
United States
Employees
237
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
NEXT
HROW
Price
$5.60
$36.36
Analyst Decision
Hold
Strong Buy
Analyst Count
2
8
Target Price
$7.50
$71.14
AVG Volume (30 Days)
2.8M
767.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$44.68
Revenue Next Year
N/A
$40.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.75
$20.85
52 Week High
$12.12
$54.98

Technical Indicators

Market Signals
Indicator
NEXT
HROW
Relative Strength Index (RSI) 54.63 28.17
Support Level $5.58 $36.23
Resistance Level $6.32 $40.64
Average True Range (ATR) 0.38 2.95
MACD 0.03 -1.89
Stochastic Oscillator 42.00 8.30

Price Performance

Historical Comparison
NEXT
HROW

About NEXT NextDecade Corporation

NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas, the sale of LNG, and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions, advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: